Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 33, Issue 1, Pages 290-302
Publisher
Informa UK Limited
Online
2017-12-27
DOI
10.1080/14756366.2017.1412314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
- (2017) Qi Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors
- (2017) Katerina Babkova et al. Future Medicinal Chemistry
- Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation
- (2017) Katarina Spilovska et al. MOLECULES
- The pharmacology of tacrine at N -methyl- d -aspartate receptors
- (2017) Martin Horak et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Design, synthesis, in vitro and in vivo evaluation of tacrine–cinnamic acid hybrids as multi-target acetyl- and butyrylcholinesterase inhibitors against Alzheimer's disease
- (2017) Yao Chen et al. RSC Advances
- Discovery of new acetylcholinesterase and butyrylcholinesterase inhibitors through structure-based virtual screening
- (2017) Yao Chen et al. RSC Advances
- Adamantane – A Lead Structure for Drugs in Clinical Practice
- (2016) Katarina Spilovska et al. CURRENT MEDICINAL CHEMISTRY
- AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease
- (2016) Yu Wang et al. Current Neuropharmacology
- Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease
- (2016) Laís Flávia Nunes Lemes et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Old and new acetylcholinesterase inhibitors for Alzheimer’s disease
- (2016) Daniela Galimberti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Tacrine–Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity
- (2015) Eugenie Nepovimova et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and in vitro testing of 7-methoxytacrine-amantadine analogues: a novel cholinesterase inhibitors for the treatment of Alzheimer’s disease
- (2015) Katarina Spilovska et al. MEDICINAL CHEMISTRY RESEARCH
- Design, synthesis and bioevaluation of tacrine hybrids with cinnamate and cinnamylidene acetate derivatives as potential anti-Alzheimer drugs
- (2015) Catarina Quintanova et al. MedChemComm
- Discovery of new scaffolds from approved drugs as acetylcholinesterase inhibitors
- (2015) Yao Chen et al. RSC Advances
- Design, synthesis and evaluation of tacrine–flurbiprofen–nitrate trihybrids as novel anti-Alzheimer’s disease agents
- (2013) Yao Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of novel tacrine–rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease
- (2013) Su-Yi Li et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Decreased acetylcholine release delays the consolidation of object recognition memory
- (2012) Xavier De Jaeger et al. BEHAVIOURAL BRAIN RESEARCH
- Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation
- (2012) Huang Tang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Tacrine–Ferulic Acid–Nitric Oxide (NO) Donor Trihybrids as Potent, Multifunctional Acetyl- and Butyrylcholinesterase Inhibitors
- (2012) Yao Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine—new tacrine derivate with cholinergic properties
- (2011) Jan Korabecny et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multi-Target-Directed Ligands in Alzheimer's Disease Treatment
- (2011) M. Bajda et al. CURRENT MEDICINAL CHEMISTRY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Advances in metal-induced oxidative stress and human disease
- (2011) Klaudia Jomova et al. TOXICOLOGY
- Tacrine Derivatives and Alzheimers Disease
- (2010) V. Tumiatti et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis and In Vitro Evaluation of New Tacrine Derivates-Bis-Alkylene Linked 7-MEOTA
- (2010) Jan Korabecny et al. LETTERS IN ORGANIC CHEMISTRY
- Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases
- (2009) Latha Devi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- MTDL Design Strategy in the Context of Alzheimers Disease: From Lipocrine to Memoquin and Beyond
- (2009) M. Bolognesi et al. CURRENT PHARMACEUTICAL DESIGN
- New insights into brain BDNF function in normal aging and Alzheimer disease
- (2008) Lucia Tapia-Arancibia et al. BRAIN RESEARCH REVIEWS
- Oxidative Stress Signaling in Alzheimers Disease
- (2008) B. Su et al. Current Alzheimer Research
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
- From Dual Binding Site Acetylcholinesterase Inhibitors to Multi-Target-Directed Ligands (MTDLs): A Step Forward in the Treatment of Alzheimers Disease
- (2008) Maria Bolognesi et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started